RECURRENT MOLAR PREGNANCY- A RARE CASE REPORT
Abstract
Hydatidiform moles are abnormal conception characterised by hydropic degeneration of villi and atypical proliferation of trophoblasts. Molar pregnancies are generally sporadic and the recurrence risk increases about 2 after a single molar pregnancy and it is about 10 to 23 after two or more hydatidiform moles. Presenting an interesting case of recurrent hydatidiform mole in 4 consecutive pregnancies.
Full Text:
PDFReferences
Lorigan PC, Sharma S, BrightN,ColemanRE, Hancock BW.Characteristics of women with recurrent molar pregnancies.GynaecolOncol 2007;78;288-92.
SebireNJ, FisherRA, FoskettM, Rees H, Sekl M, Newslands E. Risk of recurrent hydatidiform mole and
subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.BJOG2003:110;
Michel, J. And S. Edwards. 2003. Gestational trophoblastic tumours. In: R. W.Shaw.(editor). Shaw’s text book of gynaecoiogy. 3rd ed. London: Black well Sci.,pp: 117- 123.
Berkowitz RS, IM SS, BernsteinMR,Goldstein DP. Gestational trophoblastic disease.Subsequent pregnancy outcome,including repeat molar pregnancy. J Reprod Med1998;43;81-6.
SebireNJ, Seckl MJ. Gestational trophoblastic disease: Current management of hydatidiform mole 2008;337:452-8.
Pour Reza M,Agheli N, BaghefiSB.Serumcreatinine and urea and protein level changes in hydatidiform mole JAMA 1974;230;580-1.
PalmerJR, Driscoll SG, Rosenberg L, Berkowitz RS, Lurain JR, Soper J, et al. Oral contraceptive pills in gestational trophoblastic tumours. J Natl Cancer Inst 1999; 91:635-40.
Moglabey YB, Kircheisen R, Seoudd M, El m ogharbel N, Van den VeyverI,Slim R. Genetic map maternal locus responsibie fir familial hydatidiform moles. Hum Mol Genet 1999;8:667-71
Zhao J, Moss J, Sebire NJ, Cui QC; Sekl MJ Xiang Y, Fisher RA. Analysis of the chromosomal region 19q 13.4 in two Chinese families with recurrent hydatidiform mole. Hum Reprod 2006; 21:536-41.
Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic disease.Gynaecol Oncol2009;112:654-652.
Kohorn EI. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia J Reprod Med 2002; 47:445-450.
GoldsteinDP, Vzanten –Przybysz I, BernsteinMR,etal.Rivised FIGO staging system for gestational disease recommendations regarding therapy.JReprod Med1998;43:37-4,
Homesly HD, Blessing JA, Rettenmaier M, et al: Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.Obstet Gynaecol72:413,1988.
Reubinoff BE, Lewin A, Verner M, Safran A, Schenker JG, AbeliovichD. Intracytoplasmic sperm Injection combined with periimplantation genetic diagnosis for the recurrent gestational trophoblastic disease. Hum Reprod 1997;12:805-8.
BerkowitzRS,Goldstein DP. Current management of gestational trophoblastic disease.GynaecolOncol 2009;112:654-662.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr MGR Medical University